UMSOM researchers identify safety of a potential new treatment to manage complications from sickle cell disease - EurekAlert
Safety of a potential new treatment to manage complications from sickle cell disease
FDA approves gene-editing treatment for sickle cell disease
FDA approves world's first CRISPR gene-editing drug for sickle cell disease
FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease
Historic FDA approval of the first CRISPR-Cas9 drug for Sickle Cell Disease based on discoveries from Jennifer Doudna & Emmanuelle Charpentier, CRISPR Therapeutics & Vertex Pharmaceuticals.
The first CRISPR therapy approved in the U.S. will treat sickle cell disease
CRISPR gene therapy for sickle cell disease and β-thalassemia gets UK approval
United Kingdom approves first-ever CRISPR treatment, a cure for sickle cell disease and beta thalassemia
A new cure for sickle cell disease may be coming. Health advisers will review it next week
F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease
